Is Vaxcyte, Inc. (PCVX) a Buy, Sell, or Hold?
NASDAQ : PCVX
Vaxcyte, Inc. — News
$54.08 USD
-$1.88 (-3.36%)
- Volume
- 745.12K
- Average Volume
- 1.57M
- Market Capitalization
- $7.81B
- P/E Ratio
- -7.85
- Dividend Yield
- 0.00%
- Price Target
- $89.00
- Year High
- $65.00
- Year Low
- $29.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.49
| Source | Headline |
|---|---|
|
Bank of New York Mellon Corp Has $27.57 Million Stock Holdings in Vaxcyte, Inc. $PCVX
Bank of New York Mellon Corp lifted its holdings in shares of Vaxcyte, Inc. (NASDAQ: PCVX) by 5.6% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 474,526 shares of the company's stock after purchasing an additional 25,163 defenseworld.net - 2026-07-28 03:16:04 |
|
Vaxcyte to Participate in Upcoming Investor Conferences
SAN CARLOS, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in and host one-on-one meetings at the following investor conferences: globenewswire.com - 2026-07-08 16:05:00 |
|
Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults
First-in-Human Study Evaluating VAX-A1, a Potential Best-in-Class Vaccine Candidate Designed to Provide Broad Protection Against Disease Caused by Group A Streptococcus globenewswire.com - 2026-06-02 16:05:00 |
|
Vaxcyte, Inc. (PCVX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Vaxcyte, Inc. (PCVX) Presents at Bank of America Global Healthcare Conference 2026 Transcript seekingalpha.com - 2026-05-12 19:10:45 |
|
Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
Enrollment Now Completed for OPUS-1, OPUS-2 and OPUS-3 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults globenewswire.com - 2026-05-06 16:05:00 |
